The Legend Capital-backed radiology-imaging technology provider received $23m in a series B round led by Sherpa Venture Capital.
Nanovision Technology, a China-based radiology-imaging system developer backed by Legend Capital – the venture capital firm launched by conglomerate Legend Holdings – has secured RMB160m ($23m) in funding, VCbeat has reported.
Venture capital firm Sherpa Venture Capital led the series B round, which took Nanovision’s total funding to approximately $43m, China Money Network reported.
Founded in 2014, Nanovision provides X-ray imaging technology that can produce precision images of radiology cancer treatment in a relatively short time. It will use the…
